Title:
USE OF LONG-ACTING AND LOW-ADDICTION COMPOUND IN PREPARATION OF MEDICAMENT
Document Type and Number:
WIPO Patent Application WO/2022/041172
Kind Code:
A1
Abstract:
The present application relates to use of a compound in a medicament for anti-depression, anesthesia, analgesia, improvement of cognitive function, lung protection, and treatment or prevention of amyotrophic lateral sclerosis or complex regional pain syndrome. The compound of the present application has a longer efficacy time than the existing HNK compounds, and the compound of the present application substantially does not produce addiction.
Inventors:
LI SHU PENG (CA)
ZHOU QIANG (US)
ZHOU QIANG (US)
Application Number:
PCT/CN2020/112363
Publication Date:
March 03, 2022
Filing Date:
August 31, 2020
Export Citation:
Assignee:
SHENZHEN RUIJIAN BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K31/245; A61P25/00; A61P25/16; A61P25/22; A61P25/24; A61P25/28
Foreign References:
| CN104395283A | 2015-03-04 | |||
| CN110559282A | 2019-12-13 | |||
| CN110167541A | 2019-08-23 | |||
| CN110218157A | 2019-09-10 | |||
| CN109311801A | 2019-02-05 |
Attorney, Agent or Firm:
SHENZHEN J&Q INTELLECTUAL PROPERTY CO.,LTD. (CN)
Download PDF:
Previous Patent: LONG-ACTING AND LOW-ADDICTION COMPOUND AND PREPARATION METHOD THEREFOR
Next Patent: WEAK SOCIAL INTERACTION METHOD, CLIENT, AND SYSTEM
Next Patent: WEAK SOCIAL INTERACTION METHOD, CLIENT, AND SYSTEM